Pharmacy Benefit Managers (PBMs) play a significant role in the U.S. healthcare system, managing prescription drug benefits on behalf of health insurers. However, there's growing concern about their opaque business practices and potential for profiteering at the expense of patients and pharmacies. PBMs have been accused of charging higher prices to patients while paying lower amounts to pharmacies, pocketing the difference in what's known as "spread pricing". This practice has led to increased costs for consumers and financial strain on independent pharmacies.

According to a report by Bloomberg Law, spread pricing by PBMs cost Medicaid programs nearly $300 million in 2019 alone (Bloomberg Law). Additionally, a study published in JAMA found that PBMs and other intermediaries mark up generic drug prices by as much as 432% (JAMA).

The Federal Trade Commission (FTC) has the power to investigate these practices and enforce regulations that protect consumers from unfair or deceptive acts or practices. We call upon them now to take immediate action against PBM profiteering.

We urge you all - concerned citizens, pharmacists, healthcare providers - join us in this petition. Demand transparency from PBMs and insist on fair pricing for our essential medications. Sign this petition today!